Clinical Trial Update: Feasibility and Effects of Valaciclovir Treatment in Persons With Early Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial investigating feasibility and effects of valaciclovir in early Alzheimer's disease and mild cognitive impairment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment
• Herpes Simplex Infection

Drugs mentioned

• Valaciclovir (valaciclovir)

Snippet

Sponsor: Hugo Lovheim | Conditions: Alzheimer Disease, Mild Cognitive Impairment | Phase 2 | Status: COMPLETED